Alzheimer’s Study Links Sleep Quality to Cognition

Key Developments:

• Higher orexin levels were linked to poorer cognition
• Stronger sleep waves appeared to reduce those associations
• Sleep duration alone showed no significant orexin link
• Researchers caution that the study cannot prove causation

(Brighter Side/Neurology) — September 11, 2026: Higher levels of the wakefulness-related brain chemical orexin were associated with poorer cognitive performance and more severe neuropsychiatric symptoms in people with mild-to-moderate Alzheimer’s disease, while certain patterns of brain activity during sleep appeared to weaken those associations, according to a study published in Neurology.

The research, led by an international team including researchers from Concordia University and the Universitat de Lleida in Spain, followed 60 people with biomarker-confirmed mild-to-moderate Alzheimer’s disease. Participants were monitored for as long as 36 months.

NAZA Documentary Exposes Gaza War Claims at Venice

Nicole Kidman Recalls Feeling ‘Beyond Lonely’ After Oscar Win

PSX Under Pressure as Oil Prices Fuel Rate Hike Fears

Rather than finding a clear relationship between Alzheimer’s outcomes and the number of hours people slept, researchers found stronger associations involving the electrical activity of the brain during nonrapid eye movement (NREM) sleep.

Study Methods: “Role of Hypoxia and Sleep Fragmentation in Alzheimer Disease”. CREDIT: Neurology.

Orexin, also known as hypocretin, is a neuropeptide involved in wakefulness, sleep-wake transitions and appetite regulation. Researchers measured orexin-A in cerebrospinal fluid alongside established Alzheimer’s biomarkers, including amyloid-beta 42, phosphorylated tau181, total tau and YKL-40, which is associated with neuroinflammation.

The participants underwent overnight polysomnography at a memory clinic in Lleida, Spain. Their cognitive and neuropsychiatric performance was assessed over the subsequent three years using measures including the Alzheimer’s Disease Assessment Scale-Cognitive Subscale, Mini-Mental State Examination and memory tests.

Iranian Strike Reportedly Damages US Aircraft in Jordan

Pakistan Petrol Price Hits Rs370.80 as Oil Market Tightens

Algeria Cuts Diplomatic Ties with UAE Amid Rising Regional Tensions

Researchers reported that higher baseline cerebrospinal-fluid orexin levels were associated with poorer cognition, greater neuropsychiatric symptom severity and higher concentrations of several biomarkers associated with neurodegeneration and inflammation.

CSF Orexin, NREM SP-SO Activity, and Cognition: Bidirectional Relationships and Moderating Effects. CREDIT: Neurology.

The study found an average cerebrospinal-fluid orexin concentration of 757.3 picograms per millilitre. Women in the study had higher average orexin concentrations than men, although the researchers noted that women also showed greater spindle density and spindle power.

The more notable finding involved two forms of NREM brain activity: sleep spindles and slow oscillations.

Sleep spindles are short bursts of brain activity that occur during NREM sleep and are associated with memory processing. Slow oscillations are much slower patterns of brain activity that are also involved in the coordination and stability of brain networks during sleep.

Seerat offers guidance on workers’ rights and economic justice, Rana Shamshad

PMML calls for stronger local governments, new administrative units

Fake Fire Extinguishers Exposed at PIMS After Newborn Tragedy

The researchers found that stronger spindle activity and certain characteristics of slow oscillations were associated with better cognitive performance. These sleep-related patterns also appeared to reduce some of the negative associations between elevated orexin and cognitive and neuropsychiatric outcomes.

In statistical analyses, greater spindle activity was associated with weaker orexin-related declines in global cognition, verbal memory, visual memory and neuropsychiatric symptoms. Longer or stronger slow oscillations showed similar moderating relationships in some cognitive measures.

Importantly, the researchers did not find that total sleep time itself was significantly associated with cerebrospinal-fluid orexin concentrations or cognitive outcomes. The participants slept for an average of about 260 minutes during the laboratory recording, with median sleep efficiency of 67%.

Rawalpindi Seals 594 Premises, Registers 2,223 Dengue FIRs

Andrew Garfield faces Backlash over “Billionaire” Comments

Mir Raza Case: Zia Lanjar Apologises to Judicial Commission

This suggests that, at least within this study group, the quality and organization of NREM sleep may provide information that is not captured simply by measuring how long someone sleeps.

“This study shows that there is a direct association between orexin levels in the brain and biomarkers of Alzheimer’s disease,” said Thien Thanh Dang-Vu, a neurologist and professor at Concordia University.

Arsenio Paez, right, with Thanh Dang-vu: “Alzheimer’s is a very long process, so this gives us a better picture of how conditions can change over time and we might intervene at different stages of the disorder.” CREDIT: Concordia University.

The study also examined whether obstructive sleep apnea could explain the findings. Sensitivity analyses adjusting for sleep-apnea severity produced broadly similar results, suggesting that the main statistical relationships were not substantially altered by the condition.

However, the findings do not establish that elevated orexin causes cognitive decline or that stronger sleep spindles and slow oscillations directly protect against Alzheimer’s progression.

Apple unveils its first foldable iPhone, the iPhone Duo, at the ‘Surprise and Shine’ event

Seerat of Holy Prophet (PBUH) offers guidance for Pakistan’s challenges, PMML leaders

Ayesha Omar praises Sania Saeed’s role in Aap Ki Izzat

The research was observational and involved only 60 participants. It also did not include a cognitively healthy comparison group, meaning the researchers could not establish whether the observed relationships are specific to Alzheimer’s disease rather than part of normal aging or other processes.

Sleep was assessed at baseline through an overnight laboratory recording, rather than repeatedly throughout the study. The researchers therefore could not determine how changes in sleep architecture tracked with disease progression over time.

Linear Relationships Between (A) CSF Orexin at Baseline and Cognition at 12 Months and (B) Spindle Density, Power, and Duration, and Slow Oscillation Duration and CSF Orexin. CREDIT: Neurology.

The findings come as wider research continues to examine the relationship between sleep and Alzheimer’s disease. A systematic review published in Frontiers in Aging Neuroscience on September 9, 2026, examined 40 original studies and found evidence of a potentially two-way relationship between sleep disruption, neuroinflammation and Alzheimer’s-related pathology. The authors also stressed that further longitudinal and interventional research is needed to determine causality.

Pakistan Invites Pilgrims for Hazrat Amir Khusro Urs in New Delhi

Modi-Xi Bilateral Meeting Scheduled on Sidelines of BRICS Summit in New Delhi

Prince Rahim Aga Khan V Begins Seven-Day Visit to India

The new study may have implications for future research into treatments that target sleep-wake regulation. Orexin-blocking medicines are already used for insomnia and are being investigated in Alzheimer’s-related research, but the current findings do not show that such medicines can slow Alzheimer’s disease.

Researchers say future trials will need to establish whether modifying orexin activity or strengthening NREM sleep oscillations can actually influence disease progression.

“With this data, we can see how the course of people’s Alzheimer’s disease changes over time,” said co-first author Arsenio Paez. “Alzheimer’s is a very long process, so this gives us a better picture of how conditions can change over time and we might intervene at different stages of the disorder.”

Sleep spindles and slow oscillations were linked to greater resilience against high orexin levels in people with Alzheimer’s. CREDIT: Shutterstock.

The study, titled Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience, was published in Neurology, the journal of the American Academy of Neurology. It was published online on July 14 and appeared in the journal’s August 11, 2026 issue.

The researchers said larger studies involving healthy comparison groups, repeated sleep assessments and longer follow-up will be needed to determine whether NREM sleep patterns can eventually help identify patients at greater risk of cognitive decline or guide future treatment approaches.

Trump Administration Suspends Indian Cognizant’s New Green Card Sponsorship Filings

96% of Russia-India Trade Now Conducted in Rupees and Roubles: Sberbank

World Physiotherapy Day 2026: Digital Care Expands Access

Hormonal History may Help Assess Heart Risk in Women

Asim Iftikhar Appointed as Pakistan’s New Foreign Secretary

Security Forces Kill 11 India-Sponsored Terrorists in Balochistan Operations: ISPR

Brent Crude Rises Above $100 a Barrel as Middle East Conflict Escalates

Stay tuned to Baaghi TV for more. Download our app for the latest news, updates & uncensored content!